Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Resected Pancreatic Cancer
NCT02131493Phase 2Completed
- Sponsor
- Zhejiang University
- Start
- Jan 2015
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur in pancreatic cancer (PC), sponsored by Zhejiang University. Started Jan 2015; status: completed.
02
Drugs
tegafur
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT02131493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02131493.